How to Tell Skin to Rebuild — Hilo Wave and Bio-Remodeling

Hyaluronic acid is probably the ingredient you see most often on a cosmetics label. The molecule that holds water; a byword for hydration. Yet this familiar molecule has a property that gets far less attention. Change its size, and you change what it says.

Large hyaluronic acid behaves like a cushion that cradles water. Cut small, the very same molecule binds to receptors on the cell surface and reads as a signal: there is damage here — rebuild. Same substance, near-opposite roles. Hilo Wave, as a treatment, stands precisely on that difference.

Filling, seeping, and asking the skin to rebuild

Injectables that use hyaluronic acid fall into three broad families. On an ingredient list they all say "hyaluronic acid," which is why they get confused — but their goals differ.

• Fillers — heavily cross-linked, high-molecular-weight HA placed where volume has been lost. The goal is shape. It occupies space physically.
• Classic skin boosters (mesotherapy "glow" injections) — non-crosslinked low- and mid-molecular-weight HA, delivered shallowly across the whole face in many punctures. The goal is hydration. The epidermis and upper dermis plump up, and fade just as quickly.
• Bio-remodeling — the goal is neither shape nor hydration alone. It aims at the condition of the dermis itself, stimulating the skin to produce its own collagen and elastin.

Hilo Wave belongs to the third family. Which gives the shortest possible answer to "how is it different from a filler?" A filler inserts the result; bio-remodeling starts the process.

A filler inserts the result. Bio-remodeling starts the process.

Molecular weight is the message

In skin, hyaluronic acid is continuously synthesized and continuously broken down — and the size of the resulting fragments is itself information. An abundance of large molecules reads as a stable state; a rise in small fragments reads as damage has occurred, initiate repair. Cell biology has studied this size dependence for a long time.

Hilo Wave puts that principle to work through DHC (Dual Hyaluronic Acid Complex): two hyaluronic acids of different molecular weight bound into a single complex, doing two jobs at once.

What matters here is what the low-molecular-weight HA asks the cell to do. A fibroblast signalled through CD44 produces more Type I collagen — which carries the dermis's tensile strength — more Type III collagen, which forms its elastic scaffold, and more elastin. Those three are precisely what the preclinical study cited below reports together.

Note that this is not a story about the surface. Collagen and elastin are structures of the dermis, out of reach of anything applied topically, and they are what lets skin hold its shape. Filling something with water and rebuilding the vessel that holds the water are two different jobs. Where a conventional hydration injection stops at making the epidermis and upper dermis supple, bio-remodeling aims at the structure of the dermis beneath. That is where the two paths diverge.

The 24-hour problem — the case for minimal crosslinking

A fair question follows. If low-molecular-weight HA is such a good signal, why not simply inject a lot of it?

Because of time. Non-crosslinked hyaluronic acid degrades remarkably fast in skin: review literature puts its half-life there at less than a day (for comparison, minutes in blood and one to three weeks in cartilage). The signal is good, but there is no time to send it. This is also why classic skin boosters are repeated every month or two.

Push the other way and you arrive at a filler. Bind the chains tightly with a crosslinker such as BDDE and the gel persists — but it persists as a mass rather than a message. Being hard to degrade, it does not readily release the fragments a cell can read.

So this class of products takes the middle path. In Hilo Wave, half is not crosslinked at all (25% non-crosslinked low-MW plus 25% non-crosslinked high-MW) and only the other half is crosslinked minimally. The non-crosslinked portion works first; the minimally crosslinked portion gradually breaks down into non-crosslinked high- and low-MW HA. In effect, a slow-release reservoir.

One point deserves precision. "Minimal crosslinking" does not mean no crosslinker at all: as described in the preclinical work, the complex is stabilized with a trace amount of BDDE. That is exactly where it diverges from the crosslinker-free heat process used by Profhilo, and the comparison table below reflects it.

Crosslinking is not a question of more or less, but of what the crosslinking is for.

The numbers: a single 2 mL syringe of Hilo Wave holds 48 mg of HA — 24 mg per mL. That is denser than a classic skin booster (typically 10–20 mg/mL) and close to filler territory (around 20–25 mg/mL), yet the crosslinking is so different that it behaves as a spreading gel rather than a set volume. Concentration alone tells you very little about character.

Fewer punctures, wider reach — PDIT, and the cannula

The delivery method follows the same logic. Instead of the dozens of punctures mesotherapy requires, the product's standard technique is PDIT (Point Deep Inject Technique), placing it deeply at the face's key support points only — one to five points per side.

What makes that possible is the minimal crosslinking described above. Low viscosity and good flow let the gel spread along tissue planes on its own. Fewer injections follow, and with them less pain, bruising, and swelling.

Read only as "fewer needles, more comfort," though, and you have half the picture. The point is depth. Remodeling happens when the product sits in the deep dermis rather than near the surface — hence a few deep placements instead of many shallow ones. The comfort is a consequence of the design, not its purpose.

In practice, though, a second instrument enters — and the choice of instrument pairs exactly with the two actions described earlier.

When the target is texture and inner dryness across the whole face, a needle does the work. That is the PDIT just described: a few deep deposits, with the low viscosity left to carry the rest. Broadcasting the signal, in other words.

Sometimes, though, one hollow is the entire complaint. Under the eyes. The nasolabial fold. The medial cheek. Here the job is not to broadcast a signal but to place it, and that is why we reach for a cannula. Unlike a needle, which pierces and withdraws, a cannula is pushed beneath the skin and carried to the layer you want.

Its blunt tip is the whole point. Not being sharp, it slips around vessels and nerves rather than cutting through them, and it makes fewer openings in the skin. That is where the reduced bruising comes from.

The same syringe, but the hand moves differently when aiming at texture than when aiming at volume. Which is why a consultation for this treatment starts not with "how many cc" but with "what is bothering you most right now."

Small bumps (embossing) may be visible at the injection points immediately afterward; they usually settle within one to two days as the gel disperses. That is an expected course, not a failure.

The timeline — what arrives, and when

Treatments in this class typically use two sessions four weeks apart as the base course. Not a one-and-done procedure — and the reason lies in the mechanism above. Sending the signal once and stopping accumulates less response than sending it again while regeneration is underway.

The hydration you feel first is the hyaluronic acid's work; the firmness a few weeks later is your skin's. Satisfaction with this treatment therefore tends to arrive about a month in, not on the day. Put the other way: if you want a dramatic same-day change, this is not the right treatment.

Profhilo and Hilo Wave — same concept, different product

Search for bio-remodeling and Profhilo comes up almost without fail. Made by the Italian pharmaceutical company IBSA, its distinguishing feature is binding high- and low-molecular-weight HA in a 1:1 ratio using a heat process (NAHYCO) alone, with no chemical crosslinker. It is administered with the BAP (Bio Aesthetic Points) technique — ten points, five per side of the face.

Profhilo is not marketed in Korea and is not performed at COCO Clinic. It is more accurate to say that Hilo Wave — the same concept realized in a domestically licensed product — has taken that place.

One thing is worth stating plainly. A shared concept does not transfer the data. Clinical findings reported for Profhilo pertain to Profhilo; evidence for Hilo Wave has to be established for Hilo Wave (DHC) separately. Articles introducing this treatment often blur that line. It should not be blurred.

What to expect, and what not to

On the side of reasonable expectations: relief from tightness and inner dryness, a settling of rough texture, a gradual shift in dermal density and firmness over several weeks, and a naturalness that does not announce itself.

On the side of things to not expect:

• Designing contour — as described above, a cannula can supplement volume locally in the under-eye, nasolabial folds, and medial cheeks. But decisively filling a deficit to redraw the line of the face remains a filler's job. Hilo Wave's volume is less an inserted shape than the result of tissue holding water and filling out again.
• Lifting sagging tissue — if pronounced laxity is the main concern, a tool that contracts and rearranges tissue, such as RF lifting, comes first.
• A dramatic same-day change — per the timeline above, the main act begins two to four weeks later.

The people it suits, then, are usually these: those whose concern is skin quality rather than lost volume; those bothered by fine lines and dullness; those who want to avoid the artificial look of a filler; and those put off by boosters that require many punctures. When more regeneration and firmness are wanted, it is sometimes designed alongside an ECM-based treatment such as Juveacell.

The honesty of any treatment comes less from what it can do than from what it cannot. Which is why there are consultations in which we do not recommend Hilo Wave. Product specifications and pricing are set out on the Hilo Wave treatment page.

What the evidence says

The references below are for understanding the mechanism and do not guarantee individual results. In particular, cell and animal (preclinical) findings do not directly translate into effects in people.

• The "size specificity" of hyaluronan — that its actions differ by molecular weight, with large molecules and small fragments read as different signals — is an established concept in cell biology. — Cyphert et al., Int J Cell Biol, 2015;2015:563818
• The relationship between skin aging and hyaluronic acid, and HA's rapid turnover in skin, are described in review. It puts the half-life at 3–5 minutes in blood, less than a day in skin, and one to three weeks in cartilage. — Papakonstantinou et al., Dermatoendocrinol, 2012;4(3):253-258
• In a preclinical study of the same class of complex used in Hilo Wave (DHC — three components: non-crosslinked low-MW HA, non-crosslinked high-MW HA, and a minimally crosslinked hybrid stabilized with a trace amount of BDDE), fibroblast production of Type I and III collagen and elastin and antioxidant enzyme activity increased while senescence markers fell; in a UVB photoaging rat model, wrinkle depth and epidermal thickening decreased while elasticity, collagen density, hydration, and barrier measures improved. The authors write that the findings should be read as demonstrating biological plausibility, and list as limitations the absence of protein-level confirmation of key signaling nodes, the absence of a formulation-matched control (a mixture of low- and high-MW HA without the hybrid crosslinking), and the need for further clinical study in humans. — Roh et al., Int J Mol Sci, 2026;27(2):1027
• The broader research landscape for hybrid complexes of high- and low-molecular-weight HA is summarized in review. — Humzah et al., Int J Mol Sci, 2024;25(6):3216
• In a clinical study on roughness and laxity of neck skin, two injections 30 days apart produced improvement that agreed across clinical, instrumental, and self-assessment measures. Note that this study concerns the Profhilo product. — Sparavigna et al., ScientificWorldJournal, 2022;2022:4497176